• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于内镜检查和磁共振成像对接受放化疗的直肠癌患者ypT分期的预测:110例患者的前瞻性研究结果

Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.

作者信息

Cho Min Soo, Kim HonSoul, Han Yoon Dae, Hur Hyuk, Min Byung Soh, Baik Seung Hyuk, Cheon Jae Hee, Lim Joon Seok, Lee Kang Young, Kim Nam Kyu

机构信息

Division of Colon and Rectal Surgery, Yonsei University College of Medicine.

Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine.

出版信息

Medicine (Baltimore). 2019 Aug;98(35):e16614. doi: 10.1097/MD.0000000000016614.

DOI:10.1097/MD.0000000000016614
PMID:31464897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6736480/
Abstract

Accurate tumor response determination remains inconclusive after preoperative chemoradiation therapy (CRT) for rectal cancer. This study aimed to investigate whether clinical assessment, such as endoscopy and magnetic resonance imaging (MRI), can accurately predict ypT stage and select candidates for pelvic organ-preserving surgery in rectal cancer after preoperative CRT. A total of 110 patients who underwent preoperative CRT followed by curative resection for rectal cancer were prospectively enrolled. Magnetic resonance tumor regression grade (mrTRG) using T2-MRI, endoscopic evaluation, and combination modality (combination of endoscopy and mrTRG) were used to analyze tumor response after preoperative CRT. Endoscopic findings were categorized as 3 grades and the mrTRG was assessed into 5 grades. Twenty-nine patients (26.4%) had achieved pathologic complete response. When predicting ypT0, endoscopy showed significantly higher area under the curve (AUC 0.818) than did mrTRG (AUC 0.568) and combination modality (AUC 0.768) in differentiating good response from poor response (P < .001). Both endoscopy and combination modality showed significantly higher diagnostic performance in sensitivity (79.31%), positive predictive value (PPV 67.65%), negative predictive value (NPV 92.11%), and accuracy (84.55%) than those of MR tumor response (sensitivity 37.93%, PPV 36.67%, NPV 77.50%, and accuracy 66.36%) for the prediction of ypT0 (P < .001). Combination modality showed significantly higher diagnostic performance in sensitivity (56.92%), NPV (56.92%), and accuracy (67.27%) compared with those of mrTRG. Neither endoscopy, nor mrTRG, nor the combination modality had adequate diagnostic performances to be clinically acceptable in selecting candidates for nonoperative treatment strategies. However, endoscopy may be incorporated in clinical restaging strategy in planning the extent of surgical resection in patients with rectal cancer.

摘要

对于直肠癌患者,术前放化疗(CRT)后准确判定肿瘤反应仍无定论。本研究旨在探讨诸如内镜检查和磁共振成像(MRI)等临床评估能否准确预测ypT分期,并为术前CRT后的直肠癌患者选择保留盆腔器官手术的候选者。前瞻性纳入了110例行术前CRT并随后接受直肠癌根治性切除术的患者。利用T2-MRI的磁共振肿瘤退缩分级(mrTRG)、内镜评估以及联合模式(内镜检查与mrTRG相结合)分析术前CRT后的肿瘤反应。内镜检查结果分为3级,mrTRG评估为5级。29例患者(26.4%)达到病理完全缓解。在区分反应良好与反应不佳时,预测ypT0时,内镜检查的曲线下面积(AUC 0.818)显著高于mrTRG(AUC 0.568)和联合模式(AUC 0.768)(P<0.001)。在预测ypT0方面,内镜检查和联合模式在敏感性(79.31%)、阳性预测值(PPV 67.65%)、阴性预测值(NPV 92.11%)和准确性(84.55%)方面均显示出显著高于MR肿瘤反应的诊断性能(敏感性37.93%、PPV 36.67%、NPV 77.50%、准确性66.36%)(P<0.001)。联合模式在敏感性(56.92%)、NPV(56.92%)和准确性(67.27%)方面显示出显著高于mrTRG的诊断性能。内镜检查、mrTRG或联合模式在选择非手术治疗策略的候选者方面均没有足够的诊断性能以被临床接受。然而,在规划直肠癌患者的手术切除范围时,内镜检查可纳入临床再分期策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/6736480/50a89729e875/medi-98-e16614-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/6736480/f096234122a4/medi-98-e16614-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/6736480/4aee882672eb/medi-98-e16614-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/6736480/0d3971b3e119/medi-98-e16614-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/6736480/50a89729e875/medi-98-e16614-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/6736480/f096234122a4/medi-98-e16614-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/6736480/4aee882672eb/medi-98-e16614-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/6736480/0d3971b3e119/medi-98-e16614-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/6736480/50a89729e875/medi-98-e16614-g006.jpg

相似文献

1
Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.基于内镜检查和磁共振成像对接受放化疗的直肠癌患者ypT分期的预测:110例患者的前瞻性研究结果
Medicine (Baltimore). 2019 Aug;98(35):e16614. doi: 10.1097/MD.0000000000016614.
2
Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy.新辅助放化疗后直肠癌术前局部分期的磁共振成像诊断性能。
Diagn Interv Radiol. 2023 Mar 29;29(2):219-227. doi: 10.4274/dir.2022.221333. Epub 2023 Jan 2.
3
Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.直肠癌术前放化疗后磁共振成像对病理分期的预测:KROG 10-01和11-02的汇总分析
Radiother Oncol. 2014 Oct;113(1):18-23. doi: 10.1016/j.radonc.2014.08.016. Epub 2014 Sep 19.
4
Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.术前同步放化疗 MRI 特征有利于直肠癌患者的病理完全缓解:MR T2 分期作为预测病理完全缓解的辅助发现的有用性。
J Med Imaging Radiat Oncol. 2021 Apr;65(2):166-174. doi: 10.1111/1754-9485.13132. Epub 2020 Dec 14.
5
18F-FDG PET/MRI for Rectal Cancer TNM Restaging After Preoperative Chemoradiotherapy: Initial Experience.18F-FDG PET/MRI 用于术前放化疗后直肠癌 TNM 分期的再评估:初步经验。
Dis Colon Rectum. 2020 Mar;63(3):310-318. doi: 10.1097/DCR.0000000000001568.
6
[Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].[MRI肿瘤退缩分级与表观扩散系数联合预测局部晚期直肠癌新辅助治疗后病理完全缓解的价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Apr 25;24(4):359-365. doi: 10.3760/cma.j.cn.441530-20200225-00089.
7
Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.扩散加权磁共振成像和磁共振容积测量法——用于评估局部晚期直肠癌患者术前放化疗后的肿瘤反应。
Magn Reson Imaging. 2015 Feb;33(2):201-12. doi: 10.1016/j.mri.2014.08.041. Epub 2014 Nov 13.
8
MRI-based radiomic score increased mrTRG accuracy in predicting rectal cancer response to neoadjuvant therapy.基于 MRI 的放射组学评分提高了 mrTRG 在预测直肠癌新辅助治疗反应中的准确性。
Abdom Radiol (NY). 2023 Jun;48(6):1911-1920. doi: 10.1007/s00261-023-03898-x. Epub 2023 Apr 1.
9
MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy.直肠癌新辅助放化疗后 MR 肿瘤退缩分级预测病理完全缓解的准确性:系统评价和荟萃分析
Eur Radiol. 2020 Apr;30(4):2312-2323. doi: 10.1007/s00330-019-06565-2. Epub 2020 Jan 17.
10
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.一项直肠癌可行性研究,采用嵌入式III期试验设计,评估磁共振肿瘤退缩分级(mrTRG)作为一种新的生物标志物,用于根据对放化疗的反应好坏分层管理(TRIGGER):一项随机对照试验的研究方案
Trials. 2017 Aug 29;18(1):394. doi: 10.1186/s13063-017-2085-2.

引用本文的文献

1
Long-term efficacy of transanal local excision versus total mesorectal excision after neoadjuvant treatment for rectal cancer: A meta-analysis.新辅助治疗后经肛门局部切除与全直肠系膜切除治疗直肠癌的长期疗效:一项荟萃分析。
PLoS One. 2023 Nov 20;18(11):e0294510. doi: 10.1371/journal.pone.0294510. eCollection 2023.
2
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.局部晚期直肠癌新辅助放化疗后残留扁平黏膜病变患者病理完全缓解的预测因素
Chin J Cancer Res. 2022 Aug 30;34(4):383-394. doi: 10.21147/j.issn.1000-9604.2022.04.06.
3

本文引用的文献

1
Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer.利用内镜检查结果预测直肠癌放化疗后接受观察等待患者的病理完全缓解情况及预后
Dis Colon Rectum. 2017 Apr;60(4):368-375. doi: 10.1097/DCR.0000000000000742.
2
Endoscopic evaluation of clinical response after preoperative chemoradiotherapy for lower rectal cancer: the significance of endoscopic complete response.低位直肠癌术前放化疗后临床反应的内镜评估:内镜完全缓解的意义
Int J Colorectal Dis. 2015 Mar;30(3):367-73. doi: 10.1007/s00384-014-2105-6. Epub 2015 Jan 9.
3
Surgical Treatment of Low-Lying Rectal Cancer: Updates.
低位直肠癌的外科治疗:进展
Ann Coloproctol. 2021 Dec;37(6):395-424. doi: 10.3393/ac.2021.00927.0132. Epub 2021 Dec 22.
4
Circulating Hybrid Cells: A Novel Liquid Biomarker of Treatment Response in Gastrointestinal Cancers.循环杂交细胞:胃肠道癌治疗反应的新型液体生物标志物。
Ann Surg Oncol. 2021 Dec;28(13):8567-8578. doi: 10.1245/s10434-021-10379-2. Epub 2021 Aug 7.
5
Contemporary snapshot of tumor regression grade (TRG) distribution in locally advanced rectal cancer: a cross sectional multicentric experience.局部晚期直肠癌肿瘤退缩分级(TRG)分布的当代快照:一项横断面多中心经验。
Updates Surg. 2021 Oct;73(5):1795-1803. doi: 10.1007/s13304-021-01044-0. Epub 2021 Apr 5.
Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies.
增加直肠癌新辅助放化疗与手术之间的间隔时间:已发表研究的荟萃分析
Ann Surg. 2016 Mar;263(3):458-64. doi: 10.1097/SLA.0000000000000368.
4
Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.直肠癌新辅助放化疗后残留在肠壁中的癌细胞分布。
Dis Colon Rectum. 2013 Feb;56(2):142-9. doi: 10.1097/DCR.0b013e31827541e2.
5
Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study.在局部进展期直肠癌新辅助放化疗后,FDG-PET 与 CT 均无法区分完全病理缓解与不完全缓解:一项前瞻性研究。
Ann Surg. 2013 Aug;258(2):289-95. doi: 10.1097/SLA.0b013e318277b625.
6
Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy.新辅助治疗后完全临床缓解的直肠癌的非手术治疗。
Ann Surg. 2012 Dec;256(6):965-72. doi: 10.1097/SLA.0b013e3182759f1c.
7
MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience.局部进展期直肠癌治疗后 MRI:如何报告肿瘤反应——MERCURY 经验。
AJR Am J Roentgenol. 2012 Oct;199(4):W486-95. doi: 10.2214/AJR.11.8210.
8
Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.新辅助治疗反应作为直肠癌患者的早期反应指标。
J Clin Oncol. 2012 May 20;30(15):1770-6. doi: 10.1200/JCO.2011.39.7901. Epub 2012 Apr 9.
9
The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy.新辅助放化疗后直肠癌残留黏膜异常的手术意义。
Br J Surg. 2012 Jul;99(7):993-1001. doi: 10.1002/bjs.8700. Epub 2012 Feb 20.
10
Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?术前放化疗治疗局部进展期直肠癌能否预测病理完全缓解?
Int J Colorectal Dis. 2012 May;27(5):613-21. doi: 10.1007/s00384-011-1348-8. Epub 2011 Nov 15.